Today: 8 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Plexus stock jumps 7% in midday trade as contract manufacturers rally after CPI

Plexus stock jumps 7% in midday trade as contract manufacturers rally after CPI

Plexus Corp (PLXS) shares surged about 7% to $171.65 Tuesday, outpacing peers in a broad electronics manufacturing rally. The move followed a December inflation report showing consumer prices up 2.7% year-on-year. Analysts expect Plexus to report Q1 EPS near $1.77 on January 28. The stock now trades above the average analyst target of $159.
13 January 2026
····
SOLS stock jumps as Solstice Advanced Materials targets $220 million Virginia ballistic-fiber buildout

SOLS stock jumps as Solstice Advanced Materials targets $220 million Virginia ballistic-fiber buildout

Shares of Solstice Advanced Materials rose nearly 6% Tuesday after it announced a $220 million expansion of its ballistic fiber plant in Colonial Heights, Virginia. The company plans to add about 100 jobs by 2029 and boost production for armor materials. Investors await capex and demand updates on Feb. 11. The stock traded at $55.05 in afternoon session, up from Monday’s $52.01 close.
13 January 2026
·
Arcus Biosciences stock jumps on Goldman upgrade as traders eye JPM Healthcare stage

Arcus Biosciences stock jumps on Goldman upgrade as traders eye JPM Healthcare stage

Arcus Biosciences shares rose 4.8% to $22.32 Tuesday after Goldman Sachs upgraded the stock to “Buy” and raised its price target. The move followed early Phase 1 data for lead drug casdatifan showing response rates of 31% alone and 46% in combination for advanced kidney cancer. Arcus plans to present at the J.P. Morgan Healthcare Conference on Wednesday. The company reported $1 billion in cash and funding into late 2028.
13 January 2026
·
Roblox stock jumps as BMO flags a breakout game and Feb. 5 earnings loom (RBLX)

Roblox stock jumps as BMO flags a breakout game and Feb. 5 earnings loom (RBLX)

Roblox shares rose 8% to $83.09 in midday New York trading Tuesday, after touching $83.98 and trading as low as $76.05. The company will report fourth-quarter and full-year 2025 results after the bell on Feb. 5. BMO reiterated an Outperform rating, citing strong early performance of a new game. New York’s governor is pushing for stricter online gaming rules affecting Roblox, The Verge reported.
13 January 2026
····
Solaris Energy Infrastructure stock jumps 6% as traders chase data-center power play — what to watch next for SEI

Solaris Energy Infrastructure stock jumps 6% as traders chase data-center power play — what to watch next for SEI

Solaris Energy Infrastructure shares rose 6.4% to $54.64 in midday trading Tuesday, near a 52-week high. Analyst Bobby Brooks raised his price target to $70, citing 900 megawatts of open capacity likely to be contracted in early 2026. Solaris is scaling toward 2.2 gigawatts of operated power, with Power Solutions expected to drive future earnings. Next earnings report is estimated for Feb. 19, 2026.
13 January 2026
···
Structure Therapeutics stock jumps 14% as Roche-Genentech patent deal back in focus

Structure Therapeutics stock jumps 14% as Roche-Genentech patent deal back in focus

Structure Therapeutics shares surged about 14% midday Tuesday after a recent SEC filing revealed a $100 million upfront patent license deal with Roche’s Genentech for an oral GLP-1 drug. The stock rose to $79.24, up $9.88 from Monday’s close, as investors re-evaluated obesity-drug makers during the J.P. Morgan Healthcare Conference.
13 January 2026
····
Kennametal stock jumps on Jefferies upgrade as tungsten prices hit fresh highs

Kennametal stock jumps on Jefferies upgrade as tungsten prices hit fresh highs

Kennametal shares rose 8.4% to $33.32 midday Tuesday after Jefferies upgraded the stock and raised its price target to $40, citing a sharp spike in tungsten prices. Tungsten benchmark prices in China hit 725,000 yuan per ton, renewing concerns over raw-material costs. The stock’s rally pushed it above recent targets from UBS and Morgan Stanley. Investors await Kennametal’s earnings report on Feb. 4 for margin and demand updates.
13 January 2026
·
Scorpio Tankers stock jumps nearly 9% on net-cash update as investors eye a February catalyst

Scorpio Tankers stock jumps nearly 9% on net-cash update as investors eye a February catalyst

Scorpio Tankers shares surged nearly 9% to $59.85 by midday Tuesday after the company reported a net cash position of $164.7 million, outstripping its debt. A U.S. filing showed Scorpio agreed to sell the LR2 tanker STI Kingsway for $57.5 million, with closing expected in early 2026. Investors are watching the timing of vessel sales and related cash flows. Peers Frontline and International Seaways rose about 3%.
13 January 2026
··
Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

Option Care Health shares rose nearly 10% to $35.16 Tuesday after the company released preliminary Q4 results and doubled its share buyback authorization to $1.0 billion. The company projects Q4 net revenue of $1.46–$1.47 billion and adjusted EPS of $0.46–$0.49. A Citizens analyst raised the price target to $38, citing easing Stelara-related risk after 2026.
13 January 2026
··
1 … 242 243 244 245 246 … 588

Stock Market Today

  • Thoma Bravo to Acquire Kneat for C$650 Million in Cash Deal
    June 8, 2026, 1:37 PM EDT. Thoma Bravo, the world's largest software-focused investment firm, has agreed to acquire Kneat, a leader in digital validation and quality process automation, for approximately C$650 million. Kneat shareholders will receive C$6.50 per share in cash, representing a 40% premium over the unaffected closing price prior to a strategic review announcement. The deal, pending shareholder and regulatory approval, will see Kneat become privately held. Kneat's platform, crucial for data integrity and traceability in life sciences, supports regulatory compliance and AI deployment. Thoma Bravo aims to accelerate Kneat's growth and industry leadership post-acquisition. The board highlighted the deal's immediate value and recognition of Kneat's strong market position.

Latest articles

ASML Sets New European Valuation Record; Broadcom Shows Risks in AI

ASML Sets New European Valuation Record; Broadcom Shows Risks in AI

8 June 2026
ASML’s market value soared to a European record of $691.8 billion as analysts raised estimates for its EUV machine output, driving U.S. shares up 7.1% after JPMorgan and Morgan Stanley hiked price targets, with investors betting on ASML’s control of critical chipmaking tools amid surging AI demand and factory expansions planned for 2026.
Meta $145 Billion AI Push Faces Snag With Wall Street

Meta $145 Billion AI Push Faces Snag With Wall Street

8 June 2026
Meta shares fell 0.8% to $587.97 Monday after reports the company may sell tens of billions in new stock to fund AI infrastructure, raising investor concerns about dilution as capital spending soars and AI financing shifts from earnings to equity markets; Meta has not hired banks and may still consider other financing options.
Palantir’s $200 Target Meets Doubts on AI Growth

Palantir’s $200 Target Meets Doubts on AI Growth

8 June 2026
Palantir shares steadied at $135.73 after a volatile week, as investors weighed 85% Q1 revenue growth and a raised 2026 forecast against a steep 96x forward earnings valuation, with analysts warning that any slowdown in U.S. commercial or government revenue, or a shift in AI sentiment, could sharply impact the stock’s high multiple.
Go toTop